Cefotaxime vs Ceftriaxone for the Prolongation of Latency Period in Preterm Premature Rupture of Membranes

• Main Authors: Shinta Dewi Rasti, -, Maftuchah Rochmanti, -, Relly Yanuari Primariawan, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Internet Medical Publishing 2020
• Subjects: R Medicine (General); RM Therapeutics. Pharmacology
• Online Access: https://repository.unair.ac.id/111380/1/Cefotaxime%20vs%20ceftriaxone%20for%20the%20prolongation%20of%20latency%20period%20in%20preterm%20premature%20rupture%20of%20membranes.pdf; https://repository.unair.ac.id/111380/2/12.%20Email%20acceptance_Maftuchah%20with%20Shinta%20Dewi%20R_IAJAA.pdf; https://repository.unair.ac.id/111380/3/Cefotaxime%20vs%20ceftriaxone%20for%20the.pdf; https://repository.unair.ac.id/111380/4/Cefotaxime%20vs%20ceftriaxone%20for%20the%20prolongation%20of%20latency%20period%20in%20preterm%20premature%20rupture%20of%20membranes.pdf; https://repository.unair.ac.id/111380/; http://imed.pub/ojs/index.php/IAJAA/article/view/2361; https://doi.org/10.3823/839
• Institution: Universitas Airlangga

Introduction: Antibiotics are well known and recommended as the main therapy for preterm premature rupture of membranes (PPROM.) But the research on antibiotics other than the recommended macrolides regimens is still lacking. This research aims to evaluate whether there are effects differences of ce...